The invention provides a human ena/VASP-like protein splice variant (EVL1)
and polynucleotides which identify and encode EVL1. The invention also
provides expression vectors, host cells, antibodies, agonists, and
antagonists. The invention also provides methods for treating or
preventing disorders associated with expression of EVL1.